OverviewSuggest Edit

Lonza (also known as Lonza Biologics) is a company that supplies active ingredients, chemical intermediates, and biotechnology solutions to the pharmaceutical and agrochemical industries. It also offers organic intermediates for a range of applications, such as pharmaceuticals, agrochemicals, vitamins, food and feedstuff, dyes and pigments, adhesives, and fragrances. The company also manufactures specialty biocides and oleochemicals; and develops and produces specific polymer intermediates, unsaturated polyester-resins, compounds, and composites.
TypePublic
Founded1897
HQBasel, CH
Websitelonza.com
Employee Ratings3.3
Overall CultureC+

Latest Updates

Employees (est.) (Jun 2021)17,153(+4%)
Job Openings952
Revenue (FY, 2020)CHF4.5 B(-23%)
Share Price (Nov 2021)CHF729.8
Cybersecurity ratingAMore
Discover new suppliers and conduct deeper comparison analysis with Craft for EnterpriseLearn more
Banner background

Key People/Management at Lonza

Pierre-Alain Ruffieux

Pierre-Alain Ruffieux

Chief Executive Officer (CEO) and Member of the Executive Committee
Albert M. Baehny

Albert M. Baehny

Chairman of the Board of Directors, Independent member of the Board of Directors of Lonza Group
Rodolfo J. Savitzky

Rodolfo J. Savitzky

Chief Financial Officer (CFO) and Member of the Executive Committee
Stefan Stoffel

Stefan Stoffel

Head, Group Operations and Member of the Executive Committee
Caroline Barth

Caroline Barth

Chief Human Resources Officer (CHRO) and Member of the Executive Committee
Christoph Mäder

Christoph Mäder

Vice-Chairman of the Board of Directors of Lonza Group Ltd; Independent member of the Board of Directors of Lonza Group Ltd
Show more

Lonza Office Locations

Lonza has offices in Basel, Monteggio, Stein, Visp and in 54 other locations
Basel, CH (HQ)
Lonza-Hochhaus, Münchensteinerstrasse 38
Basel, CH
Hochbergerstrasse 70
Monteggio, CH
Via Cantonale 4
Stein, CH
Schaffhauserstrasse 101
Baulkham Hills, AU
12 Century Cct
Brooklyn, AU
35/640-680 Geelong Rd
Show all (62)

Lonza Financials and Metrics

Lonza Revenue

Embed Graph
View revenue for all periods
Lonza's revenue was reported to be CHF4.51 b in FY, 2020 which is a 23.9% decrease from the previous period.
CHF

Revenue (H1, 2021)

2.5b

Gross profit (H1, 2021)

1.0b

Gross profit margin (H1, 2021), %

41%

Net income (H1, 2021)

321.0m

EBITDA (H1, 2021)

988.0m

EBIT (H1, 2021)

317.0m

Market capitalization (10-Nov-2021)

54.2b

Closing stock price (10-Nov-2021)

729.8

Cash (30-Jun-2021)

501.0m

EV

57.4b
Lonza's current market capitalization is CHF54.2 b.
Annual
CHFFY, 2018FY, 2019FY, 2020

Revenue

5.5b5.9b4.5b

Revenue growth, %

9%7%(24%)

Cost of goods sold

3.4b3.7b2.7b

Gross profit

2.1b2.3b1.8b
Half Year
CHFH1, 2019H1, 2020H1, 2021

Revenue

3.0b3.1b2.5b

Revenue growth, %

(48%)

Cost of goods sold

1.8b1.9b1.5b

Gross profit

1.1b1.2b1.0b
Annual
CHFFY, 2018FY, 2019FY, 2020

Cash

461.0m505.0m495.0m

Accounts Receivable

692.0m715.0m

Prepaid Expenses

181.0m256.0m

Inventories

1.3b1.1b
Half Year
CHFH1, 2019H1, 2020H1, 2021

Cash

413.0m552.0m501.0m

Current Assets

2.9b3.1b5.0b

Total Assets

13.5b13.9b15.2b

Short-term debt

637.0m330.0m858.0m
Annual
CHFFY, 2018FY, 2019FY, 2020

Net Income

563.0m646.0m871.0m

Depreciation and Amortization

526.0m526.0m

Inventories

(207.0m)(129.0m)

Accounts Payable

77.0m(38.0m)
Half Year
CHFH1, 2019H1, 2020H1, 2021

Net Income

30.0m478.0m321.0m

Cash From Operating Activities

166.0m434.0m549.0m

Purchases of PP&E

(308.0m)(416.0m)(516.0m)

Cash From Investing Activities

269.0m(470.0m)(435.0m)
CHFFY, 2018

Revenue/Employee

366.3k

Debt/Equity

0.6 x

Debt/Assets

0.3 x

Financial Leverage

2.2 x
Show all financial metrics

Lonza Operating Metrics

FY, 2016FY, 2017FY, 2018FY, 2019FY, 2020

Manufacturing and R&D Facilities

40537055

Patent Families

650630575569

Countries

30303030

Clinical Development Programs (Pharma and Biotech)

350575730820
Show all operating metrics

Lonza Acquisitions / Subsidiaries

Company NameDateDeal Size
Octane BiotechOctober 31, 20118chf58 m
Micro-MacinazioneJuly 26, 2017chf67 m
CapsugelJuly 05, 2017chf3.3 b
PharmaCellMay 03, 2017chf33 m
InterHealth NutraceuticalsSeptember 12, 2016chf240 m
Triangle Research LabsApril 27, 2016chf15 m
Diacon TechnologiesOctober 01, 2015chf12 m
Zelam HoldingsAugust 03, 2015
Arch Acquisition LLC
Arch Chemicals Canada, Inc.
Show more

Lonza Revenue Breakdown

Embed Graph

Lonza revenue breakdown by business segment: 25.8% from Capsules & Health Ingredients, 48.0% from Biologics, 15.5% from Small Molecules and 10.8% from Cell & Gene

Human Capital Metrics

Lonza's employees are reported to be approximately 33% female and 67% male.
Embed Graph
Show all human capital metrics

Lonza Cybersecurity Score

Cybersecurity ratingPremium dataset

A

94/100

SecurityScorecard logo

Lonza Environment, Social & Governance (ESG) Ratings

CSRHub ESG ratingPremium dataset

50-59

out of 100

CSRHub logo

Lonza Online and Social Media Presence

Embed Graph

Lonza Company Culture

  • Overall Culture

    C+

    67/100

  • CEO Rating

    B

    72/100

  • Compensation

    A+

    83/100

  • Diversity

    C

    63/100

Learn more on Comparably

Lonza News and Updates

Global Antibody Drug Conjugates Contract Manufacturing Market (2021 to 2028) - Featuring Lonza, Catalent and Siegfried Among Others

Dublin, Nov. 02, 2021 (GLOBE NEWSWIRE) -- The "Antibody Drug Conjugates Contract Manufacturing Market Size, Share & Trends Analysis Report By Condition (Myeloma, Lymphoma, Breast Cancer), By Linker (Cleavable Linker, Non-cleavable Linker), By Region, And Segment Forecasts, 2021 - 2028" report …

Lonza to Acquire Codiak BioSciences Exosomes Manufacturing Facility and Establish a Long-Term Strategic Collaboration

BASEL, Switzerland and CAMBRIDGE, Mass., Nov. 02, 2021 (GLOBE NEWSWIRE) -- Lonza, a global manufacturing partner to the pharma, biotech and nutrition industries, announced today the acquisition of an exosome manufacturing facility located in Lexington, Massachusetts (US) from Codiak BioSciences (N…

Lonza to Acquire Exosomics Service Unit to Expand Exosomes Service Offering

Lonza, a global manufacturing partner to the pharmaceutical, biotech and nutrition industries, announced today the acquisition of the service unit from Exosomics, a leading extracellular vesicles biotech company. The agreement includes Exosomics' service team, service assets and laboratories in Sien…

Capital Markets Day 2021: Lonza to Capture Market Demand and Ensure Sustainable Value Creation Through Long-Term Growth

At its Capital Markets Day hosted today, Lonza provided more details of the company’s strategic priorities at a Group and divisional level. The following key priorities support the company's continuing commitment to sustainable value creation:

Lonza to Expand Development Services for Mammalian Products in Singapore

Lonza, a global manufacturing partner to the pharma, biotech and nutrition industries, today announced it will invest to expand mammalian development services in Singapore. The expansion will establish additional capacity for cell culture, purification, and analytical services for mammalian biologic…

Lonza to Expand Drug Product Manufacturing Network in Switzerland

Lonza will invest to expand its drug product manufacturing network in Switzerland.
Show more

Lonza Frequently Asked Questions

  • When was Lonza founded?

    Lonza was founded in 1897.

  • Who are Lonza key executives?

    Lonza's key executives are Pierre-Alain Ruffieux, Albert M. Baehny and Rodolfo J. Savitzky.

  • How many employees does Lonza have?

    Lonza has 17,153 employees.

  • What is Lonza revenue?

    Latest Lonza annual revenue is CHF4.5 b.

  • What is Lonza revenue per employee?

    Latest Lonza revenue per employee is CHF262.8 k.

  • Who are Lonza competitors?

    Competitors of Lonza include Bristol-Myers Squibb, Royal DSM and Catalent.

  • Where is Lonza headquarters?

    Lonza headquarters is located at Lonza-Hochhaus, Münchensteinerstrasse 38, Basel.

  • Where are Lonza offices?

    Lonza has offices in Basel, Monteggio, Stein, Visp and in 54 other locations.

  • How many offices does Lonza have?

    Lonza has 62 offices.